| Sol No.: |
Navy SBIR FY2010.1 |
| Topic No.: |
N101-085 |
| Topic Title: |
Hemostatic Agent Development |
| Proposal No.: |
N101-085-1139 |
| Firm: |
Hybrid Plastics
55 W. L. Runnels Industrial Dr.
Hattiesburg, Mississippi 39401-8320 |
| Contact: |
Joseph Lichtenhan |
| Phone: |
(601) 544-3466 |
| Web Site: |
www.hybridplastics.com |
| Abstract: |
The proposed effort comprises a treatment combination using the platelet binding hemostatic capability of Nanoscopic Chemicals known as POSS trisilanols in combination with hyaluronic acid media, and antibiotic drugs in liquid and foam form. Mechanistically, liquid POSS trisilanols are injectable and serve to bind platelets to immediately stop bleeding. Subsequently the bound plateles release a multitude of natural growth factors while in the presence of a supplement of Hyaluronic acid (HA). Growth factors in combination with high amounts of HA are known to aid tissue repair and preservation. |
| Benefits: |
Wounded soldier care at the time of injury will be improved. Potential for increased care of emergency room surgeries and increase rate of recovery for surgical patients and reduced scar tissue formation. |